NEW YORK (GenomeWeb) – The US Food and Drug Administration (FDA) announced today that it is offering a panel of human plasma samples to assist in the regulatory evaluation of serological tests to detect recent Zika virus infection.
To read the full story....
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?
Login Now.
Don't have a 360Dx or GenomeWeb account?
Register for Free.